Michaelides, Michel
Moorfields Eye Hospital NHS Foundation Trust · Moorfields Eye Hospital · University College London
16 papers on CoChatORCID 0000-0002-1552-7046
Most cited papers
- Verified
Long-Term Effect of Gene Therapy on Leber’s Congenital Amaurosis
Bainbridge, J. W. B., Mehat, M. S., Sundaram, V., Robbie, S. J., Barker, S. E., Ripamonti, C., Georgiadis, A., Mowat, F. M., Beattie, S. G., Gardner, P. J., et al. (2015) · New England Journal of Medicine
Retinal Development and DisordersVirus-based gene therapy research
Cited by 743
- Verified
Whole-genome sequencing of patients with rare diseases in a national health system
Turro, E., Astle, W. J., Megy, K., Gräf, S., Greene, D., Shamardina, O., Allen, H. L., Sanchis-Juan, A., Frontini, M., Thys, C., et al. (2020) · Nature
Genomics and Rare DiseasesGenetic Associations and Epidemiology
Cited by 554
- Verified
Leber congenital amaurosis/early-onset severe retinal dystrophy: clinical features, molecular genetics and therapeutic interventions
Kumaran, N., Moore, A. T., Weleber, R. G., & Michaelides, M. (2017) · British Journal of Ophthalmology
Retinal Development and DisordersRetinal Diseases and Treatments
Cited by 334
- Verified
Macular dystrophies: Clinical and imaging features, molecular genetics and therapeutic options
Rahman, N., Georgiou, M., Khan, K. N., & Michaelides, M. (2020) · British Journal of Ophthalmology
Retinal Development and DisordersRetinal Diseases and Treatments
Cited by 139
- Verified
Mapping of a novel locus for achromatopsia (ACHM4) to 1p and identification of a germline mutation in the α subunit of cone transducin (GNAT2)
Aligianis, I. A., Forshew, T., Johnson, S., Michaelides, M., Johnson, C. A., Trembath, R. C., Hunt, D. M., Moore, A. T., & Maher, E. R. (2002) · Journal of Medical Genetics
Retinal Development and DisordersPhotoreceptor and optogenetics research
Cited by 130
- Verified
The Impact of Inherited Retinal Diseases in the Republic of Ireland (ROI) and the United Kingdom (UK) from a Cost-of-Illness Perspective
Galvin, O., Chi, G., Brady, L., Hippert, C., Del Valle Rubido, M., Daly, A., & Michaelides, M. (2020) · Clinical Ophthalmology
Retinal Development and DisordersHealth Systems, Economic Evaluations, Quality of Life
Cited by 116
- Verified
Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65
Georgiadis, A., Duran, Y., Ribeiro, J., Abelleira-Hervas, L., Robbie, S. J., Sünkel-Laing, B., Fourali, S., Gonzalez-Cordero, A., Cristante, E., Michaelides, M., et al. (2016) · Gene Therapy
Retinal Development and DisordersVirus-based gene therapy research
Cited by 84
- Verified
Safety and Proof-of-Concept Study of Oral QLT091001 in Retinitis Pigmentosa Due to Inherited Deficiencies of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT)
Scholl, H. P. N., Moore, A. T., Koenekoop, R. K., Wen, Y., Fishman, G. A., van den Born, L. I., Bittner, A., Bowles, K., Fletcher, E. C., Collison, F. T., et al. (2015) · PLOS ONE
Retinal Development and DisordersRetinal Diseases and Treatments
Cited by 71
- Verified
Phase 1/2 AAV5-hRKp.RPGR (botaretigene sparoparvovec) gene therapy: safety and efficacy in RPGR-associated X-linked retinitis pigmentosa
MICHAELIDES, M., BESIRLI, C. G., YANG, Y., DE GUIMARAES, T. A. C., WONG, S. C., HUCKFELDT, R. M., COMANDER, J. I., SAHEL, J.-A., SHAH, S. M., TEE, J. J. L., et al. (2024) · American Journal of Ophthalmology
Retinal Development and DisordersVirus-based gene therapy research
Cited by 55
- Verified
First-in-Human gene therapy trial of AAV8-hCARp.hCNGB3 in adults and children with CNGB3-associated achromatopsia
Michaelides, M., Hirji, N., Wong, S. C., Besirli, C. G., Zaman, S., Kumaran, N., Georgiadis, A., Smith, A. J., Ripamonti, C., Gottlob, I., et al. (2023) · American Journal of Ophthalmology
Retinal Development and DisordersVirus-based gene therapy research
Cited by 54
- Verified
Retinal Structure in RPE65-Associated Retinal Dystrophy
Kumaran, N., Georgiou, M., Bainbridge, J. W. B., Bertelsen, M., Larsen, M., Blanco-Kelly, F., Ayuso, C., Tran, H. V., Munier, F. L., Kalitzeos, A., et al. (2020) · Investigative Opthalmology & Visual Science
Retinal Development and DisordersRetinal Diseases and Treatments
Cited by 44
- Verified
De Novo Truncating Mutations in WASF1 Cause Intellectual Disability with Seizures
Ito, Y., Carss, K. J., Duarte, S. T., Hartley, T., Keren, B., Kurian, M. A., Marey, I., Charles, P., Mendonça, C., Nava, C., et al. (2018) · The American Journal of Human Genetics
Genetics and Neurodevelopmental DisordersGenomics and Rare Diseases
Cited by 41
- Verified
Genetic treatment for autosomal dominant inherited retinal dystrophies: Approaches, challenges and targeted genotypes
Daich Varela, M., Georgiadis, A., & Michaelides, M. (2023) · British Journal of Ophthalmology
Retinal Development and DisordersVirus-based gene therapy research
Cited by 30
- Verified
Vitamin A deficiency due to bi-allelic mutation of RBP4: There’s more to it than meets the eye
Khan, K. N., Carss, K., Raymond, F. L., Islam, F., NIHR BioResource-Rare Diseases Consortium, Moore, A. T., Michaelides, M., & Arno, G. (2017) · Ophthalmic Genetics
Retinal Development and DisordersRetinoids in leukemia and cellular processes
Cited by 26
- Verified
Retinal detachment in retinitis pigmentosa
Chan, W. O., Brennan, N., Webster, A. R., Michaelides, M., & Muqit, M. M. K. (2020) · BMJ Open Ophthalmology
Retinal and Macular SurgeryRetinal Diseases and Treatments
Cited by 19
- Verified
Macula-predominant retinopathy associated with biallelic variants in RDH12
Ba-Abbad, R., Arno, G., Robson, A. G., Bouras, K., Georgiou, M., Wright, G., Webster, A. R., & Michaelides, M. (2020) · Ophthalmic Genetics
Retinal Development and DisordersRetinal Diseases and Treatments
Cited by 16
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free